Shinva Shines at MEDICA 2025
From November 17 to 20, 2025, the global healthcare community gathered at Messe Düsseldorf as the 57th MEDICA—one of the world’s largest and most influential medical trade fairs—officially opened. MEDICA 2025 brought together more than 5,000 exhibitors from 72 countries and approximately 80,000 visitors. As a leading enterprise in China’s medical device industry, Shinva presented its latest innovations across core business segments, showcasing the strength of China’s medical technology on the world stage.
In the Infection Control and Rehabilitation exhibition area, Shinva redefined medical safety and rehabilitation experience with its intelligent solutions. Through dynamic scenario simulations, the company demonstrated its full-process infection control system. In addition, two advanced rehabilitation devices were showcased, both designed with intelligent and user-centered concepts to help patients regain healthy, active lives and bring new momentum to the rehabilitation industry.
Shinva’s ring-type linear accelerator model also drew significant attention in the radiotherapy section. The model highlighted Shinva’s strong capabilities in the development of precision radiotherapy equipment. Its innovative design breaks foreign technological monopolies and brings safer, more efficient precision treatment options to cancer patients worldwide.
In the Surgical Instruments section, Shinva displayed a comprehensive portfolio of precision-engineered instruments, each crafted with meticulous attention to detail. The newly launched 4K endoscopic system further demonstrated Shinva’s dedication to superior quality and performance, meeting the needs of diverse surgical environments.
The Cleanroom Technology area focused on the intelligent upgrade of operating theaters. Solutions such as the electric operating table and Smart-L series surgical lights showcased Shinva’s commitment to building safer and more efficient surgical environments.
A notable highlight was the debut of Shinva’s self-developed IVD product—the SGH Series Fully Automatic Glycated Hemoglobin Analyzer—at MEDICA. Leveraging advanced technological principles, this device offers a new solution for accurate diagnosis of chronic diseases such as diabetes. Its high-efficiency and high-accuracy detection capabilities provide essential support for diabetes management.
Guided by the mission of “Advancing Health Through Innovation,” Shinva continues to explore new frontiers in medical technology. The company’s presence at MEDICA 2025 not only demonstrated its technological strength but also marked a significant step toward becoming a central player in the global healthcare ecosystem. Looking ahead, Shinva will continue to drive innovation and contribute more “Chinese strength” to the advancement of global health.
